• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday

    10/16/23 12:08:14 PM ET
    $ALHC
    $APH
    $BE
    $CNSL
    Medical Specialities
    Health Care
    Electrical Products
    Technology
    Get the next $ALHC alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.

    PCTEL, Inc. (NASDAQ:PCTI) gained 47.3% to $6.86. On Friday, Amphenol Corporation (NYSE:APH) inked a deal to acquire PCTEL for around $139.7 million.

    Almacenes Éxito S.A. (NYSE:EXTO) shares climbed 32.6% to $6.66.

    E2open Parent Holdings, Inc. (NYSE:ETWO) rose 22% to $3. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.

    Prothena Corporation plc (NASDAQ:PRTA) climbed 19.7% to $52.78.

    Alignment Healthcare, Inc. (NASDAQ:ALHC) rose 17.8% to $7.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.

    Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) gained 17.5% to $4.1493 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.

    indie Semiconductor, Inc. (NASDAQ:INDI) jumped 15% to $5.60. indie Semiconductor expects third-quarter revenue to be above $60 million, slightly higher than the company's guidance and consensus estimates.

    MoonLake Immunotherapeutics (NASDAQ:MLTX) rose 11.5% to $60.98 after the company announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab.

    ATRenew Inc. (NYSE:RERE) gained 11.3% to $1.78.

    Revolution Medicines, Inc. (NASDAQ:RVMD) climbed 11.3% to $33.30 after the company on Friday announced preliminary clinical data for RMC-6236 and RMC-6291.

    SunOpta Inc. (NASDAQ:STKL) rose 11.2% to $3.9450.

    Overstock.com, Inc. (NASDAQ:OSTK) surged 10.5% to $16.61. Overstock.com 13D filing showed JAT Capital Mgmt LP reported a 9.1% stake in the company as of Oct. 12.

    Lululemon Athletica Inc. (NASDAQ:LULU) climbed 9.8% to $414.67 after it was announced the stock will join the S&P 500.

    Puyi Inc. (NASDAQ:PUYI) jumped 8.8% to $5.68.

    Snap Inc. (NYSE:SNAP) gained 8.4% to $9.40.

    Tuya Inc. (NYSE:TUYA) rose 8.3% to $1.6350.

    QuinStreet, Inc. (NASDAQ:QNST) climbed 7.8% to $10.08.

    Bloom Energy Corporation (NYSE:BE) gained 7.6% to $12.30.

    Trinity Industries, Inc. (NYSE:TRN) rose 7.4% to $23.52. Susquehanna upgraded Trinity Industries from Neutral to Positive and raised the price target from $29 to $32.

    Varonis Systems Inc (NASDAQ:VRNS) gained 7.3% to $32.80 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.

    Sinclair, Inc. (NASDAQ:SBGI) climbed 7.2% to $10.43.

    SMART Global Holdings, Inc. (NASDAQ:SGH) gained 6.6% to $13.97.

    Market gains and prices at the time of writing.

    Now Read This: Ethereum Tops This Key Level; Bitcoin SV Emerges As Top Gainer

    Photo: Shutterstock

    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC
    $APH
    $BE
    $CNSL

    CompanyDatePrice TargetRatingAnalyst
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    Bloom Energy Corporation
    $BE
    1/28/2026$153.00Equal Weight
    Barclays
    Bloom Energy Corporation
    $BE
    1/28/2026$207.00Buy
    China Renaissance
    Varonis Systems Inc.
    $VRNS
    1/26/2026$41.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ALHC
    $APH
    $BE
    $CNSL
    SEC Filings

    View All

    MoonLake Immunotherapeutics filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - MoonLake Immunotherapeutics (0001821586) (Filer)

    2/23/26 6:04:46 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    indie Semiconductor Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - indie Semiconductor, Inc. (0001841925) (Filer)

    2/19/26 4:35:33 PM ET
    $INDI
    Semiconductors
    Technology

    Prothena Corporation plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PROTHENA CORP PUBLIC LTD CO (0001559053) (Filer)

    2/19/26 4:07:15 PM ET
    $PRTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALHC
    $APH
    $BE
    $CNSL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Snap upgraded by Arete with a new price target

    Arete upgraded Snap from Neutral to Buy and set a new price target of $7.30

    2/10/26 7:58:39 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    TD Cowen reiterated coverage on Bloom Energy with a new price target

    TD Cowen reiterated coverage of Bloom Energy with a rating of Hold and set a new price target of $160.00 from $105.00 previously

    2/6/26 8:24:09 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    Snap upgraded by Stifel with a new price target

    Stifel upgraded Snap from Sell to Hold and set a new price target of $5.50

    2/6/26 8:05:59 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ALHC
    $APH
    $BE
    $CNSL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference

    ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday, March 10, at 3:40 p.m. EST. A webcast and replay of the presentation will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Adv

    2/23/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    lululemon Announces 100th Store Opening in EMEA

    Milestone location will be the first lululemon store in Poland and will open with franchise partner Arion Retail Group lululemon (NASDAQ:LULU) today announced the upcoming opening of the 100th lululemon store in its Europe, Middle East, and Africa (EMEA) market, marking a significant milestone in the brand's international expansion journey. Across EMEA, lululemon stores are a blend of company- and franchise-operated locations, reflecting the brand's agile and considered approach to growth. Through its franchise partnership agreement with Arion Retail Group, the 100th lululemon location will open on March 13 in Warsaw, Poland, becoming the first lululemon store in the country. This 100th

    2/23/26 6:30:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

    In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% of patients achieving ASAS40 by Week 12Consistently, other clinical and imaging scores also showed improvements of 80+% by week 12 for patients treated with SLK, including ASDAS-CRP and SPARCC MRIaxSpA is a disease driven by inflammation leading to irreversible ossification (via osteoblast activity) and ultimately to irreversible restriction of mobility – objective PET/MRI imaging data further showed a significant reduction in inflammation and osteoblast activity deep in affected joints, already by week 12, suggesting potential for disease modifica

    2/22/26 11:00:00 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALHC
    $APH
    $BE
    $CNSL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, President, Chairman Faitelson Yakov bought $598,907 worth of shares (26,725 units at $22.41), gifted 87,000 shares, received a gift of 78,928 shares and was granted 315,674 shares, increasing direct ownership by 14% to 2,098,387 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:31:52 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    EVP Engineering & CTO Bass David was granted 169,095 shares and bought $69,941 worth of shares (2,980 units at $23.47), increasing direct ownership by 20% to 1,042,924 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:27:11 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    Director Gavin John J Jr bought $112,700 worth of shares (5,000 units at $22.54), increasing direct ownership by 2% to 273,666 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:24:17 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    $ALHC
    $APH
    $BE
    $CNSL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ALHC
    $APH
    $BE
    $CNSL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Digital Officer Mansour Adnan R. was granted 23,441 shares (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/23/26 5:14:30 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Chief Operations Officer Chitoori Satish sold $211,982 worth of shares (1,521 units at $139.37), decreasing direct ownership by 0.66% to 230,017 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/19/26 8:10:11 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Officer Soderberg Shawn Marie sold $465,014 worth of shares (3,332 units at $139.56), decreasing direct ownership by 1% to 219,871 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/19/26 8:09:32 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $ALHC
    $APH
    $BE
    $CNSL
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

    Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene's clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA, "Imagene, " or the "Company")), today announced the appointment of Dr. Ben Porter-Brown, a seasoned autoimmune and inflammatory drug developer with experience in the OX40 receptor-ligand (OX40-OX40L) inhibition field, as its Chief Medical Officer. He will be fo

    2/10/26 7:00:00 AM ET
    $IMA
    $MLTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Amphenol Announces Board Succession Plan

    Amphenol Corporation (NYSE:APH) today announced that the Board of Directors has appointed R. Adam Norwitt, currently serving as President and Chief Executive Officer, to the additional role of Chairman of the Board, effective on the date of the Company's 2026 Annual Meeting of Stockholders, which is expected to be in May 2026. After more than five decades with Amphenol, including serving as President from 1987 to 2006, Chief Executive Officer from 1996 to 2008 and as Chairman of the Board since 1997, Martin H. Loeffler intends to retire from the Board also effective in May. As part of this leadership transition, David P. Falck, who has served as a Director since 2013 and Presiding Director

    2/4/26 4:44:00 PM ET
    $APH
    Electrical Products
    Technology

    $ALHC
    $APH
    $BE
    $CNSL
    Financials

    Live finance-specific insights

    View All

    indie Reports Fourth Quarter 2025 Results

    Delivered Q4 2025 Revenue of $58M, up 8% sequentially, exceeding the midpoint of the outlook by $1M Commenced first radar chipset shipments to Tier 1 partner indie Semiconductor, Inc. (NASDAQ:INDI), an automotive solutions innovator, today announced fourth quarter results for the period ended December 31, 2025. Q4 revenue was $58.0 million. On a GAAP basis, fourth quarter 2025 operating loss was $33.9 million compared to $33.9 million a year ago. Non-GAAP operating loss for the fourth quarter of 2025 was $10.1 million, compared to $14.2 million a year ago, representing continued progress towards profitability. Fourth quarter 2025 GAAP loss per share was $0.16, while Non-GAAP loss per

    2/19/26 4:30:00 PM ET
    $INDI
    Semiconductors
    Technology

    Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights

    Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year of 2025, respectively; quarter-end cash and restricted cash position was $308.4 million Prothena expects the full year 2026 net cash used in operating and investing activities to be $50 to $55 million and expects to end the year with approximately $255 million in cash (midpoint). Financial guidance does not include the potential to earn up to $105 million in aggregate clinical milestone payments from strategic partners in 2026 Roche initiated the Phase 3 PARAISO trial evaluating prasinezumab in early-stage Parkinson's disease in 4Q 2025; primary completion exp

    2/19/26 4:05:00 PM ET
    $PRTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026

    REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, February 25, 2026, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines' senior management team will host a webcast to discuss the financial results for the quarter and full year, and provide an update on corporate progress. To listen to the live webcast, or access the archived webcast, please visit: https://ir.revmed.com/events-and-prese

    2/18/26 4:05:00 PM ET
    $RVMD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALHC
    $APH
    $BE
    $CNSL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Tuya Inc.

    SC 13G - Tuya Inc. (0001829118) (Subject)

    12/4/24 9:00:55 PM ET
    $TUYA
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by E2open Parent Holdings Inc.

    SC 13G/A - E2open Parent Holdings, Inc. (0001800347) (Subject)

    11/14/24 4:34:20 PM ET
    $ETWO
    EDP Services
    Technology